20S proteasome inhibitors (Fudan University)

N/A

Report date: 2025/01/26 15:54:10

Base Information

Drug Name20S proteasome inhibitors (Fudan University)
Drug Alias Namebortezomib derivatives (Fudan University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesFudan University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A